Skip to main content
. 2018 Jan 15;33(3):302–308. doi: 10.5606/ArchRheumatol.2018.6418

Table 2. Efficacy of mizoribine and methotrexate.

  Mizoribine (n=14) Methotrexate (n=10)  
  n Mean±SE n Mean±SE p
Prednisone dose          
0-48 week (mg)   1907±241   2272±396 0,41
0-24 week (mg)   1288±163   1311±207 0,93
24-48 week (mg)   619±92   962±232 0,14
At baseline (mg/day)   12.1±1.8   11.4±1.8 0,70
At 48 week (mg/day)   2.6±0.5   4.7±1.1 0,07
≤5 mg at 48 week 13   6   0,12
Patients who ceased prednisone 3   1   0,62
Flare-ups 5   2   0,65
SE: Standard error.